Capecitabine
7 Inquiries
154361-50-9
Pharmaceutical Grade
99%
LIANYUNGANG
25kg/0.2kg Bag
2017-05-19
Capecitabine,Fludarabine,Cisatracurium besylate,Atracurium,4-Chloro-N-methylpicolinamide,Decitabine
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Capecitabine
Other Name:Cytidine,5′-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-;Carbamic acid,[1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-,pentyl ester;5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;Ro 09-1978/000;Capecitabine;Ro 09-1978;5′-Deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine;Xeloda;Capecitibine;Capecytabine;Capiibine;Captabin;N4-Pentyloxycarbonyl-5′-deoxy-5-fluorocytidine;Capacetrine;Ecansya;Capecitabine Medac;Capecitabine Accord;Capecitabine Teva;Capecitabine SUN;Xeltabin;158798-73-3;958887-39-3
CAS No.:154361-50-9
Molecular Formula:C15H22FN3O6
InChIKeys:InChIKey=GAGWJHPBXLXJQN-UORFTKCHSA-N
Molecular Weight:359.35000
Exact Mass:359.35
UNII:6804DJ8Z9U
DSSTox ID:DTXSID3046451
NCI Thesaurus Code:C1794
Color/Form:White to off-white crystalline powder|Crystals from ethyl acetate
ATC Code:L01BC06|L - Antineoplastic and immunomodulating agents
HScode:2934999090
Categories:
Characteristics-
PSA:
122.91000
XLogP3:0.6
Appearance:white to beige
Density:1.49 g/cm3
Melting Point:88-89 °C
Boiling Point:437.874ºC at 760 mmHg
Flash Point:218.619ºC
Refractive Index:1.7
Water Solubility:2.48e-01 g/L
Storage Conditions:Store in original container in a cool dark place.
Vapor Pressure:0mmHg at 25°C
Henrys Law Constant:Henry's Law constant = 2.9X10-19 atm-cu m/mol at 25 °C (est)
Dissociation Constants:pKa1 = 1.9 (amide)
Experimental Properties:Hydroxyl radical reaction rate constant = 8.27X10-11 cu cm/molec-sec at 25 °C (est)|Ozone reaction rate constant = 7.0X10-15 cu cm/molec-sec at 25 °C (est)
Hazard IdentificationClassification of the substance or mixture
Germ cell mutagenicity, Category 2
Carcinogenicity, Category 1B
Reproductive toxicity, Category 1B
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H341 Suspected of causing genetic defects
H350 May cause cancer
H360 May damage fertility or the unborn child
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Capecitabine,Fludarabine,Cisatracurium besylate,Atracurium,4-Chloro-N-methylpicolinamide,Decitabine
-
Location:
Ganyu Economic Development Zone, Liuliqiao Private Industrial Park, No. 406
-
Payment Terms:
D/P,L/C
-
Average lead Time:
60
-
Total Annual Revenue:
Less than $1 million
Lianyungang Shenghe Biological Technology Co., Ltd. is mainly engaged in the development and production of anti-tumor drug intermediates. The company has complete environmental protection, safety, firefighting procedures, complete public facilities, has relatively complete analysis and testing equipment including liquid chromatograph, gas chromatograph, etc. and has established a relatively complete quality management system. The company has a city-level technology center, a city-level high-tech enterprise, and a green synthesis laboratory jointly established with Jiangsu Marine Resources Research Institute.
"Technology is the first productive force" and "Technology achieves the future". The company adheres to the strategy of science and technology and talents. At present, the company has 2 PhDs, masters and undergraduates account for more than 60% of the company's staff, and hires several domestic and foreign drug synthesis experts. Guide the company's research and development all the year round, and has established its own characteristics in the research and development of anti-tumor drug intermediates, with many excellent technologies. The company has rich experience in R&D, production, and management, and has developed into a domestic manufacturer and supplier of highly competitive anti-tumor drug intermediates
-
-
Inquiry History7 Inquiries
Country Product Purchase Quantity Date Posted
United Arab Emirates
Capecitabine
150.00 KG Jul 23, 2024
Turkey
Capecitabine
100 KG Oct 21, 2025
Japan
Capecitabine(GMP+CEP)
100 G May 13, 2024
Democratic Republic of the Congo
Capecitabine
1 MT Dec 8, 2025
Turkey
Capcetabine
100 KG Nov 27, 2025
Pakistan
Capecitabine
1 KG Sep 26, 2025
Spain
Capecitabine
500 MG Oct 23, 2024 Post an enquiry for this product
Hot Related Products
-
Pentyl chloroformate -
China Most Professional Factory Supply High Qulity 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine CAS 161599-46-8 -
2,3-Di-O-acetyl-5-deoxy-5-fuluro-D-cytidine -
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine 99% white powder kanbei -
High quality n-Pentanol CAS NO.71-41-0 -
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine 99% high purity certified Professional Producer Greenbo